Division of Gastroenterology, Hepatology and Nutrition Evaluation Of Fecal And Serum Asca Levels As Ibd Diagnostic Parameters

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Division of Gastroenterology, Hepatology and Nutrition

Principal Investigator: Paul Rufo, MD, MMSc

Trial Description: The purpose of this research is to study and compare the levels of Anti-Saccharomyces cerevisiae antibodies (ASCA) in both the blood and stool of pediatric patients diagnosed with Inflammatory Bowel Disease (IBD). ASCA levels will be compared with disease severity, disease duration, and immunoglobulin levels. The goal of this study is to discover new ways to help physicians diagnose and treat their patients with inflammatory bowel disease without relying on invasive testing.

Study Procedure: Participants in the study will be asked to provide both stool and blood samples during the initial study visit and again 3-6 months later. Blood samples will be drawn at the sample time as clinical labs and stool samples can be sent by mail. 

Protocol Status: Open for recruitment

Compensation: Study participants will be given $10 for each stool sample provided.

Recruitment Info: Individuals 18 years or younger, who have been diagnosed with IBD or constipation.  

Recruitment Contact Name: Rajat Moman, MS

Recruitment Contact Phone: (617) 355-2962

Recruitment Contact Email: rajat.moman@childrens.harvard.edu

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close